CELC

Buller Richard E

Known title: DirectorCIK: 0001688319

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 10, 2026

Celcuity Shares Fall 17% After REVTORPYK Launch and NDA Filing. Celcuity’s stock fell 17.3% after the company announced the launch of its REVTORPYK product in the U.S. and filed a new drug application. The company also said it will present at the European Society for Medical Oncology congress, adding to the mix of upcoming events. With the price near its 14‑day support level of $87.46 and an RSI of 30.1, the move reflects a short‑term reaction to the news rather than a long‑term trend.

this person other insiders at CELC

Transaction History

CELC▲ Buy$0
CELC▼ Sell$0
CELC▼ Sell$0
CELC▲ Buy$46K
CELC▼ Sell$76K
CELC▼ Sell$233K
CELC▼ Sell$325K
CELC▼ Sell$401K
CELC▼ Sell$177K
CELC▼ Sell$52K
CELC▲ Buy$15K
CELC▼ Sell$256K
CELC▼ Sell$75K
CELC▲ Buy$17K
CELC▼ Sell$157K
CELC▼ Sell$160K
CELC▼ Sell$0
CELC▲ Buy$16K
CELC▼ Sell$108K
CELC▲ Buy$58K
CELC▼ Sell$377K
CELC▼ Sell$0
CELC▼ Sell$0
CELC▼ Sell$0
CELC▲ Buy$0
CELC▼ Sell$6K
CELC▼ Sell$6K
CELC▼ Sell$5K
CELC▲ Buy$0
CELC▼ Sell$0
CELC▼ Sell$0
CELC▼ Sell$6K
CELC▼ Sell$5K
CELC▼ Sell$5K
CELC▼ Sell$4K
CELC▼ Sell$3K
CELC▼ Sell$3K
CELC▼ Sell$4K
CELC▼ Sell$833
CELC▼ Sell$1K
CELC▼ Sell$2K
CELC▲ Buy$0
CELC▼ Sell$3K
CELC▼ Sell$3K
CELC▼ Sell$3K
CELC▼ Sell$3K
CELC▼ Sell$1K
CELC▼ Sell$1K
CELC▼ Sell$2K
CELC▼ Sell$3K
CELC▼ Sell$3K
CELC▼ Sell$5K
CELC▼ Sell$1K
CELC▲ Buy$0
CELC▼ Sell$2K
CELC▼ Sell$4K
CELC▼ Sell$4K

We use analytics to understand how market-wall is used. No personal data is sold.